Venture capital in ’23 for healthtech with Chris Moniz from HSBC Innovation Banking on Diagnosing Healthtech

Industry headlines are constantly buzzing with M&A activity and Healthtech VC investment trends.

On this episode of Diagnosing Healthtech, Jeff Englander (Healthcare Strategist) and Redox’s Sarah Bottjen (Director of Sales Enablement) delve into these topics in an interview with HSBC Innovation Banking’s Chris Moniz. 

In addition to his role as Managing Director, Chris is a contributing author to HSBC Innovation Banking’s 1H 2023 Venture Healthcare Report, which combines analytics and expertise to provide industry perspectives and actionable insight to companies and investors. 

Related Posts

Podcasts Diagnosing Healthtech

Achieving inclusive real-world data and enabling access to care with Reagan-Udall’s Susan Winckler & Carla Rodriguez-Watson on Diagnosing Healthtech

https://www.youtube.com/watch?v=rD44LBgfl98 No matter how much health data you collect, it’s only valuable if it’s inclusive of entire affected…

By Abbey Cox – December 1, 2023

Podcasts Diagnosing Healthtech

Transformative value-based care and patient trust with Dr. Kenny Cole on Diagnosing Healthtech

https://www.youtube.com/watch?v=vEz7swCs0-U It’s logical for healthcare leaders to think that pairing top-notch clinicians with the best technology would be…

By Abbey Cox – November 18, 2023

Podcasts Diagnosing Healthtech

Virtual care change strategies to improve access to healthcare in rural America with Dr. Steve North on Diagnosing Healthtech

https://www.youtube.com/watch?v=dppm8xFpLJU Telemedicine has made tremendous strides in improving availability of healthcare in rural populations, but true access to…

By Abbey Cox – November 3, 2023